The company has received a tentative approval from the United States Food & Drug Administration (USFDA) for marketing the 250 mg, 500 mg, 750 mg tablets of ...
... (US FDA) for marketing the 250mg, 500mg and 750mg tablets of Levofloxacin, which is used for treatment in a broad spectrum of bacterial infections. ...
Wockhardt has received tentative approval from the FDA for marketing the 250mg, 500mg and 750mg tablets of levofloxacin, which is used for treatment in a ...
Journal of the American Podiatric Medical Association (subscription) - Jan 21, 2010
In a Monte Carlo simulation analysis, the complicated skin infection regimen for ceftobiprole of 500 mg intravenously every 12 hours in a 1-hour infusion ...
The company will be able to market this drug in the strengths of 250 mg, 500 mg and 750 mg in the US. It may be noted that according to estimates this ...
Email this story